The Chinese pharma market opens up for business

The Chinese pharma market has always been inward-looking, with foreign investors deterred by an unfavourable regulatory climate. However, the government has implemented a raft of reforms with a view to ‘upgrading’ its life sciences sector. We find out more in the latest issue of Pharma Technology Focus.

2018-09-17T13:10:54+00:00 12 July 2018|Uncategorised|